Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	Rab GDP-dissociation inhibitor activity	GDI1 GDI2	2.58e-05	2	102	2	GO:0005093
GeneOntologyBiologicalProcess	immunoglobulin production	IGLV5-52 IGLV5-45 IGLV5-39 IGLV5-37 IGLV3-22 IGLV2-18 IGLV2-14 IGKV3D-20 IGKV3-20	4.64e-06	241	107	9	GO:0002377
GeneOntologyBiologicalProcess	production of molecular mediator of immune response	NR4A3 EVPL IGLV5-52 IGLV5-45 IGLV5-39 IGLV5-37 IGLV3-22 IGLV2-18 IGLV2-14 IGKV3D-20 IGKV3-20	7.99e-06	403	107	11	GO:0002440
GeneOntologyBiologicalProcess	lung induction	WNT2 WNT2B	7.97e-05	3	107	2	GO:0060492
GeneOntologyBiologicalProcess	foregut regionalization	WNT2 WNT2B	7.97e-05	3	107	2	GO:0060423
GeneOntologyBiologicalProcess	lung field specification	WNT2 WNT2B	7.97e-05	3	107	2	GO:0060424
GeneOntologyCellularComponent	immunoglobulin complex	IGLV5-52 IGLV5-45 IGLV5-39 IGLV5-37 IGLV3-22 IGLV2-18 IGLV2-14 IGKV3D-20 IGKV3-20	2.18e-07	166	109	9	GO:0019814
GeneOntologyCellularComponent	sarcoplasmic reticulum	XDH FSD2 KLHL41 CMYA5 MANF	9.76e-05	88	109	5	GO:0016529
GeneOntologyCellularComponent	sarcoplasm	XDH FSD2 KLHL41 CMYA5 MANF	3.29e-04	114	109	5	GO:0016528
GeneOntologyCellularComponent	extracellular matrix	COMP WNT2 WNT3 WNT2B LAMA5 MMRN1 THBS2 LOXL1 ADAMTS17 MUC5AC PCOLCE	6.33e-04	656	109	11	GO:0031012
GeneOntologyCellularComponent	external encapsulating structure	COMP WNT2 WNT3 WNT2B LAMA5 MMRN1 THBS2 LOXL1 ADAMTS17 MUC5AC PCOLCE	6.49e-04	658	109	11	GO:0030312
GeneOntologyCellularComponent	IgM immunoglobulin complex, circulating	IGKV3D-20 IGKV3-20	7.39e-04	8	109	2	GO:0071754
GeneOntologyCellularComponent	pentameric IgM immunoglobulin complex	IGKV3D-20 IGKV3-20	7.39e-04	8	109	2	GO:0071756
GeneOntologyCellularComponent	monomeric IgA immunoglobulin complex	IGKV3D-20 IGKV3-20	9.47e-04	9	109	2	GO:0071748
GeneOntologyCellularComponent	polymeric IgA immunoglobulin complex	IGKV3D-20 IGKV3-20	1.18e-03	10	109	2	GO:0071749
GeneOntologyCellularComponent	IgA immunoglobulin complex, circulating	IGKV3D-20 IGKV3-20	1.18e-03	10	109	2	GO:0071746
GeneOntologyCellularComponent	secretory IgA immunoglobulin complex	IGKV3D-20 IGKV3-20	1.18e-03	10	109	2	GO:0071751
GeneOntologyCellularComponent	collagen-containing extracellular matrix	COMP WNT2 WNT2B LAMA5 MMRN1 THBS2 LOXL1 ADAMTS17 PCOLCE	1.83e-03	530	109	9	GO:0062023
Domain	Wnt2	WNT2 WNT2B	2.84e-05	2	100	2	IPR009140
Domain	RabGDI	GDI1 GDI2	2.84e-05	2	100	2	IPR000806
Domain	Wnt	WNT2 WNT3 WNT2B	1.36e-04	19	100	3	IPR005817
Domain	WNT1	WNT2 WNT3 WNT2B	1.36e-04	19	100	3	PS00246
Domain	Wnt_CS	WNT2 WNT3 WNT2B	1.36e-04	19	100	3	IPR018161
Domain	wnt	WNT2 WNT3 WNT2B	1.36e-04	19	100	3	PF00110
Domain	WNT1	WNT2 WNT3 WNT2B	1.36e-04	19	100	3	SM00097
Domain	GDI	GDI1 GDI2	1.69e-04	4	100	2	PF00996
Domain	GDP_dissociation_inhibitor	GDI1 GDI2	1.69e-04	4	100	2	IPR018203
Domain	TSP_3	COMP THBS2	2.81e-04	5	100	2	PF02412
Domain	TSP3	COMP THBS2	2.81e-04	5	100	2	PS51234
Domain	TSP_CTER	COMP THBS2	2.81e-04	5	100	2	PS51236
Domain	Thrombospondin_3_rpt	COMP THBS2	2.81e-04	5	100	2	IPR017897
Domain	TSP_type-3_rpt	COMP THBS2	2.81e-04	5	100	2	IPR028974
Domain	-	COMP THBS2	2.81e-04	5	100	2	4.10.1080.10
Domain	Thrombospondin_C	COMP THBS2	2.81e-04	5	100	2	IPR008859
Domain	TSP_C	COMP THBS2	2.81e-04	5	100	2	PF05735
Domain	Thrombospondin_3-like_rpt	COMP THBS2	2.81e-04	5	100	2	IPR003367
Domain	EGF_CA	COMP MMRN1 THBS2 TLL2 C1R	5.03e-04	122	100	5	SM00179
Domain	EGF-like_Ca-bd_dom	COMP MMRN1 THBS2 TLL2 C1R	5.41e-04	124	100	5	IPR001881
Domain	Ig_I-set	FLT4 NRCAM SPEG IGSF10 FCRL1 UNC5C	5.53e-04	190	100	6	IPR013098
Domain	I-set	FLT4 NRCAM SPEG IGSF10 FCRL1 UNC5C	5.53e-04	190	100	6	PF07679
Domain	-	FLT4 NRCAM SPEG IL20RA FSD2 CMYA5 IFNGR1 IGSF10 FCRL1 SIGIRR UNC5C	8.37e-04	663	100	11	2.60.40.10
Domain	FN3_dom	NRCAM SPEG IL20RA FSD2 CMYA5 IFNGR1	9.10e-04	209	100	6	IPR003961
Domain	ConA-like_dom	COMP LAMA5 FSD2 CMYA5 MMRN1 THBS2	1.16e-03	219	100	6	IPR013320
Domain	EGF_CA	COMP THBS2 TLL2 C1R	1.17e-03	86	100	4	PF07645
Domain	Ig-like_fold	FLT4 NRCAM SPEG IL20RA FSD2 CMYA5 IFNGR1 IGSF10 FCRL1 SIGIRR UNC5C	1.39e-03	706	100	11	IPR013783
Domain	EGF	COMP LAMA5 MMRN1 THBS2 TLL2 C1R	1.66e-03	235	100	6	SM00181
Domain	IGc2	FLT4 NRCAM SPEG IGSF10 FCRL1 UNC5C	1.66e-03	235	100	6	SM00408
Domain	Ig_sub2	FLT4 NRCAM SPEG IGSF10 FCRL1 UNC5C	1.66e-03	235	100	6	IPR003598
Domain	Tissue_fac	IL20RA IFNGR1	1.81e-03	12	100	2	PF01108
Domain	Tissue_factor	IL20RA IFNGR1	1.81e-03	12	100	2	IPR001187
Domain	-	USP54 MITD1	2.13e-03	13	100	2	1.20.58.280
Domain	EGF-like_dom	COMP LAMA5 MMRN1 THBS2 TLL2 C1R	2.22e-03	249	100	6	IPR000742
Domain	CUB	TLL2 C1R PCOLCE	2.30e-03	49	100	3	PF00431
Domain	CUB	TLL2 C1R PCOLCE	2.43e-03	50	100	3	SM00042
Domain	MIT	USP54 MITD1	2.48e-03	14	100	2	IPR007330
Domain	GPCR_3_CS	GRM2 GABBR2	2.48e-03	14	100	2	IPR017979
Domain	CNH	MINK1 MAP4K4	2.48e-03	14	100	2	SM00036
Domain	EGF_1	COMP LAMA5 MMRN1 THBS2 TLL2 C1R	2.50e-03	255	100	6	PS00022
Domain	-	TLL2 C1R PCOLCE	2.72e-03	52	100	3	2.60.120.290
Domain	EGF-like_CS	COMP LAMA5 MMRN1 THBS2 TLL2 C1R	2.80e-03	261	100	6	IPR013032
Domain	CNH	MINK1 MAP4K4	2.85e-03	15	100	2	PF00780
Domain	CNH	MINK1 MAP4K4	2.85e-03	15	100	2	PS50219
Domain	CNH_dom	MINK1 MAP4K4	2.85e-03	15	100	2	IPR001180
Domain	CUB	TLL2 C1R PCOLCE	2.87e-03	53	100	3	PS01180
Domain	EGF_2	COMP LAMA5 MMRN1 THBS2 TLL2 C1R	3.02e-03	265	100	6	PS01186
Domain	CUB_dom	TLL2 C1R PCOLCE	3.53e-03	57	100	3	IPR000859
Domain	FN3	NRCAM SPEG IL20RA FSD2 CMYA5	4.34e-03	199	100	5	PS50853
Domain	TSP_1	THBS2 UNC5C ADAMTS17	4.69e-03	63	100	3	PF00090
Domain	TSP1	THBS2 UNC5C ADAMTS17	5.12e-03	65	100	3	SM00209
Domain	TSP1_rpt	THBS2 UNC5C ADAMTS17	5.12e-03	65	100	3	IPR000884
Domain	TSP1	THBS2 UNC5C ADAMTS17	5.12e-03	65	100	3	PS50092
Pubmed	Activation of C1r by proteolytic cleavage.	IGLV5-45 IGLV5-37 IGLV3-22 IGLV2-18 IGLV2-14 IGKV3D-20 C1R	8.16e-11	43	111	7	1249422
Pubmed	Recognition of immunoglobulins by Fcgamma receptors.	IGLV5-45 IGLV5-37 IGLV3-22 IGLV2-18 IGLV2-14 IGKV3D-20 IGKV3-20	1.84e-10	48	111	7	11955599
Pubmed	Sequence and evolution of the human germline V lambda repertoire.	IGLV5-52 IGLV5-45 IGLV5-39 IGLV5-37 IGLV3-22 IGLV2-18 IGLV2-14	2.14e-10	49	111	7	8951372
Pubmed	Physicochemical and functional characterization of the C1r subunit of the first complement component.	IGLV5-45 IGLV5-37 IGLV3-22 IGLV2-18 IGLV2-14 C1R	8.90e-09	47	111	6	814163
Pubmed	One-megabase sequence analysis of the human immunoglobulin lambda gene locus.	IGLV5-52 IGLV5-45 IGLV5-37 IGLV3-22 IGLV2-18 IGLV2-14	1.43e-06	109	111	6	9074928
Pubmed	Gene trap screening as an effective approach for identification of Wnt-responsive genes in the mouse embryo.	WNT2 WNT3 WNT2B	6.82e-06	12	111	3	15778975
Pubmed	Extracellular matrix remodelling in response to venous hypertension: proteomics of human varicose veins.	COMP LAMA5 APOB THBS2 LOXL1 PCOLCE	7.78e-06	146	111	6	27068509
Pubmed	Ryanodine receptors are part of the myospryn complex in cardiac muscle.	FSD2 CMYA5	1.01e-05	2	111	2	28740084
Pubmed	Differential regulation of WNT2 and WNT2B expression in human cancer.	WNT2 WNT2B	1.01e-05	2	111	2	11712082
Pubmed	GCN5-mediated transcriptional control of the metabolic coactivator PGC-1beta through lysine acetylation.	KAT2A PPARGC1B	1.01e-05	2	111	2	19491097
Pubmed	Identification of the MMRN1 binding region within the C2 domain of human factor V.	F5 MMRN1	1.01e-05	2	111	2	15452129
Pubmed	Cloning of a brain-type isoform of human Rab GDI and its expression in human neuroblastoma cell lines and tumor specimens.	GDI1 GDI2	1.01e-05	2	111	2	7585614
Pubmed	Human platelets contain forms of factor V in disulfide-linkage with multimerin.	F5 MMRN1	1.01e-05	2	111	2	15583744
Pubmed	Variants within the COMP and THBS2 genes are not associated with Achilles tendinopathy in a case-control study of South African and Australian populations.	COMP THBS2	1.01e-05	2	111	2	23875975
Pubmed	The antidepressant roles of Wnt2 and Wnt3 in stress-induced depression-like behaviors.	WNT2 WNT3	1.01e-05	2	111	2	27622936
Pubmed	Expression and estradiol regulation of Wnt genes in the mouse blastocyst identify a candidate pathway for embryo-maternal signaling at implantation.	WNT2 WNT3 WNT2B	1.40e-05	15	111	3	15044261
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	DSC2 LEMD3 MINK1 RAPGEF1 APOB ATP10D IFNGR1 SIGIRR PEAK1 MAP4K4	1.49e-05	569	111	10	30639242
Pubmed	Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.	DSC2 LEMD3 SPEG RNF181 LAMA5 EXT2 CYFIP2 THBS2 LOXL1 UNC5C MANF C1R LSS MAP4K4 PDZRN3 MITD1	1.51e-05	1451	111	16	30550785
Pubmed	Molecular genetic studies of Wnt signaling in the mouse.	WNT2 WNT3 WNT2B	1.72e-05	16	111	3	10585256
Pubmed	The Wnts.	WNT2 WNT3 WNT2B	1.72e-05	16	111	3	9889131
Pubmed	Wnt antagonist SFRP3 inhibits the differentiation of mouse hepatic progenitor cells.	WNT2 WNT3 WNT2B APOB	1.86e-05	49	111	4	19562671
Pubmed	Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.	FLT4 DSC2 NRCAM APOB F5 MMRN1 C1R	1.96e-05	257	111	7	16335952
Pubmed	Wnt family proteins are secreted and associated with the cell surface.	WNT2 WNT3 WNT2B	2.08e-05	17	111	3	8167409
Pubmed	Diabetes risk gene and Wnt effector Tcf7l2/TCF4 controls hepatic response to perinatal and adult metabolic demand.	DSC2 WNT2 WNT3 WNT2B	2.36e-05	52	111	4	23260145
Pubmed	Characterization of Wnt gene expression in developing and postnatal hair follicles and identification of Wnt5a as a target of Sonic hedgehog in hair follicle morphogenesis.	WNT2 WNT3 WNT2B	2.95e-05	19	111	3	11520664
Pubmed	Rare Variants in LAMA5 Gene associated with FLT4 and FOXC2 Mutations in Primary Lymphedema May Contribute to Severity.	FLT4 LAMA5	3.02e-05	3	111	2	29908552
Pubmed	RabGDIα is a negative regulator of interferon-γ-inducible GTPase-dependent cell-autonomous immunity to Toxoplasma gondii.	GDI1 GDI2	3.02e-05	3	111	2	26240314
Pubmed	Downregulation of VEGFR3 signaling alters cardiac lymphatic vessel organization and leads to a higher mortality after acute myocardial infarction.	FLT4 APOB	3.02e-05	3	111	2	30420641
Pubmed	Thrombospondin-1, -2 and -5 have differential effects on vascular smooth muscle cell physiology.	COMP THBS2	3.02e-05	3	111	2	26168731
Pubmed	[Rule of antibody structure. The primary structure of a monoclonal immunoglobulin L-chain of kappa-type, subgroup 3 (Bence-Jones protein Ti). IV. The complete amino acid sequence and its significance for the mechanism of antibody production].	IGKV3D-20 IGKV3-20	3.02e-05	3	111	2	5027703
Pubmed	Lymphatic vessel insufficiency in hypercholesterolemic mice alters lipoprotein levels and promotes atherogenesis.	FLT4 APOB	3.02e-05	3	111	2	24723556
Pubmed	Extracellular modulation of the Hedgehog, Wnt and TGF-beta signalling pathways during embryonic development.	WNT2 WNT3	3.02e-05	3	111	2	10449357
Pubmed	Multimerin 1 binds factor V and activated factor V with high affinity and inhibits thrombin generation.	F5 MMRN1	3.02e-05	3	111	2	19132231
Pubmed	Expression patterns of two human genes coding for different rab GDP-dissociation inhibitors (GDIs), extremely conserved proteins involved in cellular transport.	GDI1 GDI2	3.02e-05	3	111	2	7543319
Pubmed	Cloning, characterization, and expression of a novel GDP dissociation inhibitor isoform from skeletal muscle.	GDI1 GDI2	3.02e-05	3	111	2	7513052
Pubmed	Genome-wide association study identifies candidate genes for Parkinson's disease in an Ashkenazi Jewish population.	UNC13B WNT3	3.02e-05	3	111	2	21812969
Pubmed	In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.	COMP DSC2 CFL2 LAMA5 APOB GDI2 CYFIP2 IGLV2-14 PGAM4 C1R IGKV3-20 MITD1 PCOLCE	3.81e-05	1070	111	13	23533145
Pubmed	Promyelocytic leukemia protein interacts with the apoptosis-associated speck-like protein to limit inflammasome activation.	DRC7 LEMD3 DNAJC28	4.04e-05	21	111	3	24407287
Pubmed	Increased expression of Wnt2 and SFRP4 in Tsk mouse skin: role of Wnt signaling in altered dermal fibrillin deposition and systemic sclerosis.	WNT2 WNT3 WNT2B	4.04e-05	21	111	3	17943183
Pubmed	The WNT7b promoter is regulated by TTF-1, GATA6, and Foxa2 in lung epithelium.	WNT2 WNT3 WNT2B	4.04e-05	21	111	3	11914369
Pubmed	Epithelial Wnt10a Is Essential for Tooth Root Furcation Morphogenesis.	WNT2 WNT3 WNT2B	4.04e-05	21	111	3	31914354
Pubmed	Characterization of Wnt signaling components and activation of the Wnt canonical pathway in the murine retina.	WNT2 WNT3 WNT2B	4.66e-05	22	111	3	12815618
Pubmed	Does murine spermatogenesis require WNT signalling? A lesson from Gpr177 conditional knockout mouse models.	WNT2 WNT3 WNT2B	5.35e-05	23	111	3	27362799
Pubmed	Risk of cerebral venous thrombosis and novel gene polymorphisms of the coagulation and fibrinolytic systems.	F5 TAF1	6.03e-05	4	111	2	16155788
Pubmed	Munc13-2-/- baseline secretion defect reveals source of oligomeric mucins in mouse airways.	UNC13B MUC5AC	6.03e-05	4	111	2	18258655
Pubmed	Pathological responses to oncogenic Hedgehog signaling in skin are dependent on canonical Wnt/beta3-catenin signaling.	WNT2 WNT3 WNT2B	6.10e-05	24	111	3	19165927
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	IRS4 DSC2 LEMD3 MINK1 CYFIP2 UNC5C PEAK1 MAP4K4	6.43e-05	421	111	8	36976175
Pubmed	Activation of the Wnt-beta catenin pathway in a cell population on the surface of the forebrain is essential for the establishment of olfactory axon connections.	WNT2 WNT3 WNT2B	8.75e-05	27	111	3	17804636
Pubmed	Frizzled 1 and frizzled 2 genes function in palate, ventricular septum and neural tube closure: general implications for tissue fusion processes.	WNT2 WNT3 WNT2B	9.78e-05	28	111	3	20940229
Pubmed	Ectodermal Wnt signaling regulates abdominal myogenesis during ventral body wall development.	WNT2 WNT3 WNT2B	9.78e-05	28	111	3	24394376
Pubmed	Thrombospondin-3 augments injury-induced cardiomyopathy by intracellular integrin inhibition and sarcolemmal instability.	COMP THBS2	1.00e-04	5	111	2	30622267
Pubmed	GDI-1 preferably interacts with Rab10 in insulin-stimulated GLUT4 translocation.	GDI1 GDI2	1.00e-04	5	111	2	19570034
Pubmed	Genome-wide association study identifies two susceptibility loci for osteosarcoma.	GDI2 ADAMTS17	1.00e-04	5	111	2	23727862
Pubmed	Characterization of novel Rab6-interacting proteins involved in endosome-to-TGN transport.	GDI1 GDI2	1.00e-04	5	111	2	11929610
Pubmed	Mammalian BMP-1/Tolloid-related metalloproteinases, including novel family member mammalian Tolloid-like 2, have differential enzymatic activities and distributions of expression relevant to patterning and skeletogenesis.	TLL2 PCOLCE	1.00e-04	5	111	2	10479448
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	IRS4 DSC2 KIF26B MINK1 UNC45A SSX2IP USP54 PEAK1 MORC3 MAP4K4 SPATA13	1.00e-04	861	111	11	36931259
Pubmed	Wnt5a potentiates TGF-β signaling to promote colonic crypt regeneration after tissue injury.	WNT2 WNT3 WNT2B	1.09e-04	29	111	3	22956684
Pubmed	3D representation of Wnt and Frizzled gene expression patterns in the mouse embryo at embryonic day 11.5 (Ts19).	WNT2 WNT3 WNT2B	1.09e-04	29	111	3	18364260
Pubmed	Genetic interactions of the androgen and Wnt/beta-catenin pathways for the masculinization of external genitalia.	WNT2 WNT3 WNT2B	1.21e-04	30	111	3	19282366
Pubmed	Atlas of Wnt and R-spondin gene expression in the developing male mouse lower urogenital tract.	WNT2 WNT3 WNT2B	1.21e-04	30	111	3	21936019
Pubmed	Expression of all Wnt genes and their secreted antagonists during mouse blastocyst and postimplantation development.	WNT2 WNT3 WNT2B	1.21e-04	30	111	3	15880404
Pubmed	Overactive Wnt5a signaling disrupts hair follicle polarity during mouse skin development.	WNT2 WNT3 WNT2B	1.21e-04	30	111	3	36305473
Pubmed	Genetic mapping of mouse tumor necrosis factor-alpha converting enzyme (TACE) to chromosome 12.	NRCAM APOB	1.50e-04	6	111	2	9598327
Pubmed	Human frizzled 1 interacts with transforming Wnts to transduce a TCF dependent transcriptional response.	WNT2 WNT3	1.50e-04	6	111	2	10557084
Pubmed	The hematopoiesis-specific GTP-binding protein RhoH is GTPase deficient and modulates activities of other Rho GTPases by an inhibitory function.	GDI1 GDI2	1.50e-04	6	111	2	11809807
Pubmed	The human VK locus. Characterization of a duplicated region encoding 28 different immunoglobulin genes.	IGKV3D-20 IGKV3-20	1.50e-04	6	111	2	3351922
Pubmed	Mouse immunoglobulin chains. Pattern of sequence variation among kappa chains with limited sequence differences.	IGKV3D-20 IGKV3-20	1.50e-04	6	111	2	4691517
Pubmed	Primary structures of N-terminal extra peptide segments linked to the variable and constant regions of immunoglobulin light chain precursors: implications on the organization and controlled expression of immunoglobulin genes.	IGKV3D-20 IGKV3-20	1.50e-04	6	111	2	98179
Pubmed	The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/beta-catenin pathway.	WNT2 WNT3	1.50e-04	6	111	2	19421142
Pubmed	Mechanisms of antibody diversity: multiple genes encode structurally related mouse kappa variable regions.	IGKV3D-20 IGKV3-20	1.50e-04	6	111	2	99744
Pubmed	Differential expression of human Wnt genes 2, 3, 4, and 7B in human breast cell lines and normal and disease states of human breast tissue.	WNT2 WNT3	1.50e-04	6	111	2	8168088
Pubmed	Armet/Manf and Creld2 are components of a specialized ER stress response provoked by inappropriate formation of disulphide bonds: implications for genetic skeletal diseases.	COMP MANF	1.50e-04	6	111	2	23956175
Pubmed	Wnt/β-catenin pathway is regulated by PITX2 homeodomain protein and thus contributes to the proliferation of human ovarian adenocarcinoma cell, SKOV-3.	WNT2 WNT2B	1.50e-04	6	111	2	23250740
Pubmed	WNT5A is transported via lipoprotein particles in the cerebrospinal fluid to regulate hindbrain morphogenesis.	WNT2 WNT3 WNT2B	1.92e-04	35	111	3	30940800
Pubmed	Foxf2 in intestinal fibroblasts reduces numbers of Lgr5(+) stem cells and adenoma formation by inhibiting Wnt signaling.	WNT2 WNT3 WNT2B	1.92e-04	35	111	3	23376422
Pubmed	Comprehensive expression analysis of all Wnt genes and their major secreted antagonists during mouse limb development and cartilage differentiation.	WNT2 WNT3 WNT2B	1.92e-04	35	111	3	19185060
Pubmed	Dual regulation of planar polarization by secreted Wnts and Vangl2 in the developing mouse cochlea.	WNT2 WNT3 WNT2B	1.92e-04	35	111	3	32907846
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	IRS4 LEMD3 UNC45A USP54 PEAK1 MAP4K4	2.06e-04	263	111	6	34702444
Pubmed	Wnt/Rspondin/β-catenin signals control axonal sorting and lineage progression in Schwann cell development.	WNT2 WNT3 WNT2B	2.09e-04	36	111	3	24151333
Pubmed	C to U RNA editing mediated by APOBEC1 requires RNA-binding protein RBM47.	APOB RBM47	2.10e-04	7	111	2	24916387
Pubmed	Isolation of two novel WNT genes, WNT14 and WNT15, one of which (WNT15) is closely linked to WNT3 on human chromosome 17q21.	WNT3 WNT2B	2.10e-04	7	111	2	9441749
Pubmed	The 3' part of the immunoglobulin kappa locus of the mouse.	IGKV3D-20 IGKV3-20	2.10e-04	7	111	2	9603450
Pubmed	Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma.	LEMD3 KIF26B MINK1 CYFIP2 IFNGR1 PEAK1 MAP4K4	2.15e-04	377	111	7	38117590
Pubmed	Integrated analysis of Wnt signalling system component gene expression.	WNT2 WNT3 WNT2B	2.27e-04	37	111	3	35831952
Pubmed	Canonical WNT signaling promotes mammary placode development and is essential for initiation of mammary gland morphogenesis.	WNT2 WNT3 WNT2B	2.27e-04	37	111	3	15342465
Pubmed	Wnt11 promotes cardiomyocyte development by caspase-mediated suppression of canonical Wnt signals.	WNT2 WNT3 WNT2B	2.46e-04	38	111	3	21041481
Pubmed	Tissue-specific requirements of beta-catenin in external genitalia development.	WNT2 WNT3 WNT2B	2.46e-04	38	111	3	18635608
Pubmed	Epidermal Wnt controls hair follicle induction by orchestrating dynamic signaling crosstalk between the epidermis and dermis.	WNT2 WNT3 WNT2B	2.46e-04	38	111	3	23190887
Pubmed	Distinct requirements for cranial ectoderm and mesenchyme-derived wnts in specification and differentiation of osteoblast and dermal progenitors.	WNT2 WNT3 WNT2B	2.66e-04	39	111	3	24586192
Pubmed	Tamalin, a PDZ domain-containing protein, links a protein complex formation of group 1 metabotropic glutamate receptors and the guanine nucleotide exchange factor cytohesins.	GRM2 GABBR2	2.79e-04	8	111	2	11850456
Pubmed	Allelic variants between mouse substrains BALB/cJ and BALB/cByJ influence mononuclear cardiomyocyte composition and cardiomyocyte nuclear ploidy.	IRS4 GDI1	2.79e-04	8	111	2	32371981
Pubmed	Thrombospondins 1 and 2 are important for afferent synapse formation and function in the inner ear.	COMP THBS2	2.79e-04	8	111	2	24460873
Pubmed	C3G regulates the size of the cerebral cortex neural precursor population.	WNT2B RAPGEF1	2.79e-04	8	111	2	16858399
Pubmed	Decreased lymphatic HIF-2α accentuates lymphatic remodeling in lymphedema.	FLT4 EPAS1	2.79e-04	8	111	2	32673288
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	DSC2 LEMD3 MINK1 EXT2 UNC45A TUBGCP6 C5orf34 R3HCC1L DNAJC28 SSX2IP DNAJC12 LSS PEAK1 MAP4K4	2.80e-04	1487	111	14	33957083
Pubmed	Proteomics characterization of extracellular space components in the human aorta.	COMP LAMA5 LOXL1 PCOLCE	3.16e-04	101	111	4	20551380
Pubmed	Selected reaction monitoring mass spectrometry reveals the dynamics of signaling through the GRB2 adaptor.	IRS4 CYFIP2 GAREM2 PEAK1	3.41e-04	103	111	4	21706016
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	UNC13B NRCAM SPEG FRMPD1 DENND11 CHD6 SPATA13	3.41e-04	407	111	7	12693553
Pubmed	Impact of genetic polymorphisms on platelet function and aspirin resistance.	APOB F5	3.58e-04	9	111	2	19923980
Pubmed	Mouse Wnt receptor gene Fzd5 is essential for yolk sac and placental angiogenesis.	WNT2 WNT2B	3.58e-04	9	111	2	11092808
Cytoband	22q11.2	IGLV5-52 IGLV5-45 IGLV5-39 IGLV5-37 IGLV3-22 IGLV2-18 IGLV2-14	1.89e-08	120	111	7	22q11.2
Cytoband	Ensembl 112 genes in cytogenetic band chr22q11	IGLV5-52 IGLV5-45 IGLV5-37 IGLV3-22 IGLV2-18 IGLV2-14	5.64e-04	419	111	6	chr22q11
GeneFamily	Immunoglobulin lambda locus at 22q11.2	IGLV5-52 IGLV5-45 IGLV5-39 IGLV5-37 IGLV3-22 IGLV2-18 IGLV2-14	1.43e-07	89	81	7	353
GeneFamily	Wnt family\|Endogenous ligands	WNT2 WNT3 WNT2B	7.97e-05	19	81	3	360
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	FLT4 NRCAM SPEG IGSF10 UNC5C	7.82e-04	161	81	5	593
GeneFamily	DNA helicases	BRIP1 INO80	2.58e-03	17	81	2	1167
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	KAT2A TAF1	2.58e-03	17	81	2	486
CoexpressionAtlas	FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000	UNC13B IRS4 DSC2 NRCAM KIF26B LAMA5 CYFIP2 IGSF10 THBS2 CMIP LOXL1 SSX2IP ADAMTS17 RASEF PEAK1 RBM47 EPAS1	7.29e-06	984	106	17	Facebase_RNAseq_e10.5_Olfactory Pit_1000
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NRCAM WNT2 IGSF10 THBS2 UNC5C ADAMTS17 C1R PDZRN3 PCOLCE	1.08e-09	189	110	9	e9d5e858e320c6e9913c1ea6a54967d21eda605f
ToppCell	LPS_only-Stromal_mesenchymal\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NRCAM KIF26B WNT2 THBS2 UNC5C ADAMTS17 C1R PDZRN3 PCOLCE	1.25e-09	192	110	9	162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NRCAM KIF26B WNT2 THBS2 UNC5C ADAMTS17 C1R PDZRN3 PCOLCE	1.25e-09	192	110	9	ee085e04d5dcfb657522484ed20b8c1ddeccfe0c
ToppCell	PND14-Mesenchymal-Mesenchymal_structural\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NRCAM WNT2 IGSF10 LOXL1 UNC5C ADAMTS17 PEAK1 PCOLCE	2.68e-08	192	110	8	25492568f9cbe097b7bb1db50d8b817c80ea87d7
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NRCAM WNT2 IGSF10 UNC5C ADAMTS17 C1R PDZRN3 PCOLCE	2.68e-08	192	110	8	f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b
ToppCell	PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NRCAM WNT2 IGSF10 LOXL1 UNC5C ADAMTS17 PEAK1 PCOLCE	2.68e-08	192	110	8	de9c1536d5aee86f9c62acbc54ca8fa581c00f17
ToppCell	LPS-IL1RA-Stromal_mesenchymal\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NRCAM WNT2 THBS2 UNC5C ADAMTS17 C1R PDZRN3 PCOLCE	2.68e-08	192	110	8	4e47a02007f562f29ba5910df64d32a0167d0bd1
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NRCAM KIF26B IGSF10 UNC5C ADAMTS17 C1R PDZRN3 PCOLCE	2.91e-08	194	110	8	89b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCell	PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NRCAM WNT2 IGSF10 LOXL1 UNC5C ADAMTS17 PEAK1 PCOLCE	3.03e-08	195	110	8	3a0cad69cfc150a27a0666f612f5294c817197d7
ToppCell	PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NRCAM WNT2 IGSF10 LOXL1 UNC5C ADAMTS17 PEAK1 PCOLCE	3.03e-08	195	110	8	2b8ee7990267bb52b7e6ae03f509ffebf8908122
ToppCell	IPF-Stromal-Myofibroblast\|World / Disease state, Lineage and Cell class	COMP WNT2 THBS2 LOXL1 UNC5C C1R PDZRN3 PCOLCE	3.15e-08	196	110	8	7fc9894ceb79dab9f0495acc84e2d6d0d1c69bb7
ToppCell	IPF-Stromal-Myofibroblast\|IPF / Disease state, Lineage and Cell class	COMP WNT2 THBS2 LOXL1 UNC5C C1R PDZRN3 PCOLCE	3.15e-08	196	110	8	2d0a48e49b3b37bb66e33e74c52915911e1f8a74
ToppCell	10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	UNC13B NRCAM LAMA5 KAT2A IGSF10 C1R ACAP3 PCOLCE	3.15e-08	196	110	8	b8b9801181d7604871b48aebacb295d0a57a5eaf
ToppCell	P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	NRCAM WNT2 IFNGR1 LOXL1 ADAMTS17 PEAK1 PCOLCE	2.61e-07	174	110	7	3c47d069bd836599a8d40eae485c23d4d3487517
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	WNT2 GAREM2 LOXL1 UNC5C ADAMTS17 PEAK1 PCOLCE	3.16e-07	179	110	7	948c2a01ec7a626c68281e6e796a9f0527a88591
ToppCell	facs-Lung-nan-3m-Mesenchymal-fibroblast_of_lung\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRCAM WNT2 IGSF10 LOXL1 ADAMTS17 PEAK1 PCOLCE	3.54e-07	182	110	7	c557de6ccd327c46e0a5423cd9936d78e0abae5f
ToppCell	facs-Lung-nan-3m-Mesenchymal-Alveolar_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRCAM WNT2 IGSF10 LOXL1 ADAMTS17 PEAK1 PCOLCE	3.54e-07	182	110	7	dbe4b2557cf19e0682ed446f8397d3a1153642f0
ToppCell	E16.5-samps-Mesenchymal\|E16.5-samps / Age Group, Lineage, Cell class and subclass	NRCAM WNT2 LOXL1 UNC5C ADAMTS17 PEAK1 PCOLCE	4.40e-07	188	110	7	3f0f662be684e3a4c6652e636cc135a39a1d2790
ToppCell	Fibroblast-A\|World / shred on cell class and cell subclass (v4)	NRCAM WNT2 LOXL1 UNC5C ADAMTS17 PEAK1 PCOLCE	4.40e-07	188	110	7	6740bed5fb8f45b6eea17041894b804214c2a4ae
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NRCAM WNT2 IGSF10 LOXL1 UNC5C PDZRN3 PCOLCE	4.56e-07	189	110	7	a153b83314cf52808f685296cff8c95af3f4983d
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NRCAM KIF26B THBS2 UNC5C ADAMTS17 C1R PDZRN3	4.73e-07	190	110	7	45df8fee00f8949937863159d7aa042e72748d9b
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NRCAM WNT2 THBS2 LOXL1 UNC5C PDZRN3 PCOLCE	4.73e-07	190	110	7	d60395739458d7f47a3350ade751fe3819500320
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NRCAM WNT2 IGSF10 THBS2 UNC5C PDZRN3 PCOLCE	4.90e-07	191	110	7	b13229bb7f3713a392271aaf5dbae3edd1b9fe5a
ToppCell	metastatic_Lymph_Node-Fibroblasts-Myofibroblasts\|metastatic_Lymph_Node / Location, Cell class and cell subclass	COMP WNT2 THBS2 LOXL1 C1R PDZRN3 PCOLCE	4.90e-07	191	110	7	aa43b472bc8362f79ae63f09f1ca764718bbf22c
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COMP KIF26B THBS2 LOXL1 UNC5C PDZRN3 PCOLCE	5.07e-07	192	110	7	67e845e513e76e820f55e2f0d15eb16f2944d05c
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KIF26B WNT2 UNC5C ADAMTS17 C1R PDZRN3 PCOLCE	5.07e-07	192	110	7	df1545670370fb1010c567cd059c2783eab315f7
ToppCell	PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	UNC13B NRCAM CYFIP2 MTMR7 RASEF RBM47 MUC5AC	5.07e-07	192	110	7	b99f8236ef4ccdc75c02abea381cae6453205f6f
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NRCAM KIF26B WNT2 IGSF10 UNC5C PDZRN3 PCOLCE	5.07e-07	192	110	7	deeecd26972241846b4cb998edf0c7a87ff0c4df
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NRCAM WNT2 LOXL1 UNC5C ADAMTS17 PEAK1 PCOLCE	5.25e-07	193	110	7	8d05805295c5d3aa93aeb38be5fbefa81e1be1f0
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NRCAM WNT2 LOXL1 UNC5C ADAMTS17 PEAK1 PCOLCE	5.25e-07	193	110	7	1b2cc627b2aa002b442358bd1188d470e67ce7d9
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COMP KIF26B THBS2 UNC5C C1R PDZRN3 PCOLCE	5.25e-07	193	110	7	5de87fc94a6e58899ef4124cf4887ed3ff96163a
ToppCell	E17.5-Mesenchymal-mesenchymal_fibroblast\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	NRCAM WNT2 LOXL1 UNC5C ADAMTS17 PEAK1 PCOLCE	5.44e-07	194	110	7	f15e81ff12525523c62d13105cf264ea72205e2e
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NRCAM WNT2 LOXL1 UNC5C ADAMTS17 PEAK1 PCOLCE	5.63e-07	195	110	7	cbe518b465b4ef32797ae6b608219207c08493df
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NRCAM WNT2 LOXL1 UNC5C ADAMTS17 PEAK1 PCOLCE	5.63e-07	195	110	7	1c1135be421af98cd0077bec1ff2c4158d42aa21
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NRCAM WNT2 LOXL1 UNC5C ADAMTS17 PEAK1 PCOLCE	5.63e-07	195	110	7	598b69032a8441a23749b27863d80f7a1fc82a96
ToppCell	PND03-Mesenchymal-Mesenchymal_structural\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NRCAM WNT2 LOXL1 UNC5C ADAMTS17 PEAK1 PCOLCE	5.63e-07	195	110	7	136b06b0931a69b1241101f68c01c44c70365fd9
ToppCell	PND10-Mesenchymal-Mesenchymal_structural\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NRCAM WNT2 LOXL1 UNC5C ADAMTS17 PEAK1 PCOLCE	5.63e-07	195	110	7	11d421bbbb71425d59cbdd673e052e00d5f0a768
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NRCAM WNT2 LOXL1 UNC5C ADAMTS17 PEAK1 PCOLCE	5.63e-07	195	110	7	1f005ee1da66b539bd200aaa98f46edbbc7f12e4
ToppCell	ASK428-Epithelial-Transformed_epithelium\|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq	SPEG F5 PPARGC1B THBS2 SSX2IP C1R PCOLCE	5.63e-07	195	110	7	c750602c765a51075ba6ede78e3ba80b62374481
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NRCAM WNT2 LOXL1 UNC5C ADAMTS17 PEAK1 PCOLCE	5.63e-07	195	110	7	10f307aef8f4d9e71c501d5bcedb84d3be7a4d1b
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NRCAM WNT2 LOXL1 UNC5C ADAMTS17 PEAK1 PCOLCE	5.83e-07	196	110	7	2a885eed52f9b002c7995e11e450c7e8d7ae69e6
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NRCAM WNT2 LOXL1 UNC5C ADAMTS17 PEAK1 PCOLCE	5.83e-07	196	110	7	14246f00c90741a5f8683f377e22e3a7c99661b9
ToppCell	metastatic_Lymph_Node-Fibroblasts\|metastatic_Lymph_Node / Location, Cell class and cell subclass	COMP WNT2 THBS2 LOXL1 C1R PDZRN3 PCOLCE	5.83e-07	196	110	7	275e153347caf94edc0c50021bbab49c8696fecb
ToppCell	distal-3-mesenchymal-Fibromyocyte\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	NRCAM SPEG THBS2 KCND3 LOXL1 C1R PDZRN3	6.24e-07	198	110	7	dc93886439a378a0c71e99acb8081bfb6b6d467b
ToppCell	COVID-19-lung-Fibroblast\|COVID-19 / Disease (COVID-19 only), tissue and cell type	NRCAM KIF26B THBS2 UNC5C C1R PDZRN3 PCOLCE	6.24e-07	198	110	7	3ec01a55ade5e1627258cc3cfebb2c3207a4cb43
ToppCell	tumor_Lung-Fibroblasts-Myofibroblasts\|tumor_Lung / Location, Cell class and cell subclass	COMP KIF26B WNT2 THBS2 LOXL1 C1R PCOLCE	6.24e-07	198	110	7	31f9181dab689aabe9c6182c2ef7de65ba3f0ff6
ToppCell	distal-mesenchymal-Fibromyocyte-3\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	NRCAM SPEG THBS2 KCND3 LOXL1 C1R PDZRN3	6.24e-07	198	110	7	9d1d95e7703cfc70a8ad427e400c340dbd205db8
ToppCell	COVID-19-lung-Fibroblast\|lung / Disease (COVID-19 only), tissue and cell type	NRCAM KIF26B THBS2 KCND3 UNC5C C1R PDZRN3	6.24e-07	198	110	7	df3de77216f5c5d6141ec44d01c56b942f611838
ToppCell	distal-mesenchymal-Fibromyocyte\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	NRCAM SPEG THBS2 KCND3 LOXL1 C1R PDZRN3	6.24e-07	198	110	7	fbfac1d10e4224990a094cc84b74bbc206881423
ToppCell	Biopsy_Control_(H.)-Mesenchymal-Myofibroblasts\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	WNT2 THBS2 LOXL1 UNC5C C1R PDZRN3 PCOLCE	6.45e-07	199	110	7	7a227c239afdaebcac84644d9b2653a5f1a4be71
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	NRCAM IGSF10 UNC5C ADAMTS17 PDZRN3 SPATA13 PCOLCE	6.45e-07	199	110	7	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	distal-3-mesenchymal-Myofibroblast\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	COMP NRCAM THBS2 LOXL1 C1R PDZRN3 PCOLCE	6.45e-07	199	110	7	1f20addc0d138fec02ed6ca4c518169c568de263
ToppCell	Biopsy_Other_PF-Mesenchymal-Myofibroblasts\|Biopsy_Other_PF / Sample group, Lineage and Cell type	COMP WNT2 THBS2 LOXL1 C1R PDZRN3 PCOLCE	6.67e-07	200	110	7	e504570fd7eec1524c401b1cfa9d10822d80d994
ToppCell	distal-mesenchymal-Myofibroblast-3\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	COMP NRCAM THBS2 LOXL1 C1R PDZRN3 PCOLCE	6.67e-07	200	110	7	069c8949b33ecfdb6da32992002d4060ff6082bc
ToppCell	tumor_Lymph_Node_/_Brain-Fibroblasts-Myofibroblasts\|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass	COMP WNT2 THBS2 LOXL1 C1R PDZRN3 PCOLCE	6.67e-07	200	110	7	ca777a7d001848f6d01c613ff2bda7e4f3e20521
ToppCell	distal-mesenchymal-Myofibroblast\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	COMP NRCAM THBS2 LOXL1 C1R PDZRN3 PCOLCE	6.67e-07	200	110	7	61854a459385cd9295be37157a8f81a2c227dff3
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.4.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	WNT2 THBS2 LOXL1 MANF C1R PDZRN3 PCOLCE	6.67e-07	200	110	7	0e1f9e1622e5a0fd814a1e100f79cbca2e0dbfbb
ToppCell	Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	COMP THBS2 LOXL1 UNC5C C1R PDZRN3 PCOLCE	6.67e-07	200	110	7	54806080b5e97859ee6a4a9b4f19e22021c218f5
ToppCell	Biopsy_IPF-Mesenchymal-Myofibroblasts\|Biopsy_IPF / Sample group, Lineage and Cell type	COMP WNT2 THBS2 UNC5C C1R PDZRN3 PCOLCE	6.67e-07	200	110	7	c2c6f687c49ba790174b27c7b8b084af30b34c86
ToppCell	facs-Aorta-Heart-3m-Epithelial-epithelial_cell\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DRC7 BRIP1 WNT3 PPARGC1B TLL2 TAT	2.08e-06	151	110	6	0de76acd1b204345dce7f33be2a1ed9fbe9e6da0
ToppCell	facs-Aorta-Heart-3m-Epithelial-nan\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DRC7 BRIP1 WNT3 PPARGC1B TLL2 TAT	2.08e-06	151	110	6	20b9c8fb966c5d62ff909cc4a4616b109b78cdca
ToppCell	facs-Aorta-Heart-3m-Epithelial\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DRC7 BRIP1 WNT3 PPARGC1B TLL2 TAT	2.08e-06	151	110	6	bee48137d1f5f27a24571a59c835284651d38538
ToppCell	5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FUT10 CMYA5 THBS2 LOXL1 MUC5AC PDZRN3	3.72e-06	167	110	6	805129f887078340b260aa136b0ba19f2bd6ea03
ToppCell	5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FUT10 CMYA5 THBS2 LOXL1 MUC5AC PDZRN3	3.72e-06	167	110	6	31cf8bf2eb523f6e7e319620648ff37fc09e2601
ToppCell	5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FUT10 CMYA5 THBS2 LOXL1 MUC5AC PDZRN3	3.72e-06	167	110	6	3acb18428d1d33ad430c2fd031b1a91baee3c01d
ToppCell	droplet-Heart-HEART-1m-Endothelial-leukocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT4 NRCAM KIF26B WNT2 CYFIP2 MMRN1	4.56e-06	173	110	6	9dc7746a84f0e268a7c061e1bbcd5e31903034dc
ToppCell	facs-Lung-ENDOMUCIN-18m-Endothelial-Lymphatic_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT4 COMP WNT2B MMRN1 THBS2 HAS3	4.87e-06	175	110	6	9d082ba0e350162aa6e71b668be074b12a27c7ab
ToppCell	facs-Lung-ENDOMUCIN-18m-Endothelial-endothelial_cell_of_lymphatic_vessel\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT4 COMP WNT2B MMRN1 THBS2 HAS3	4.87e-06	175	110	6	f641f34b52aec5d047430a6f9d026e915da6c11d
ToppCell	343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-\|343B / Donor, Lineage, Cell class and subclass (all cells)	NRCAM WNT2B THBS2 LOXL1 C1R PCOLCE	5.03e-06	176	110	6	2e94bbe17c0bb65dc58b4ebc0cb829258bd7373b
ToppCell	343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)\|343B / Donor, Lineage, Cell class and subclass (all cells)	NRCAM WNT2B THBS2 LOXL1 C1R PCOLCE	5.03e-06	176	110	6	f33ab41d121b59d871ad7d48ca021524a027d2ef
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGLV5-45 IGLV2-14 FCRL1 IGKV3D-20 STAG3 IGKV3-20	5.37e-06	178	110	6	107dae8b00c4257697a63700e72bb434cdb8406f
ToppCell	facs-Brain_Non-Myeloid-Hippocampus_-18m-Mesenchymal-ependymal_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DRC7 CFAP91 F5 LOXL1 RBM47 PCOLCE	5.54e-06	179	110	6	9d7e39357b269d30ff1e8007a91f8645f3d80e73
ToppCell	facs-Brain_Non-Myeloid-Hippocampus_-18m-Mesenchymal-Ependyma\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DRC7 CFAP91 F5 LOXL1 RBM47 PCOLCE	5.54e-06	179	110	6	1611e11f5f74432627e2f57a27e352b1e46be618
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NRCAM WNT2 IGSF10 ADAMTS17 PDZRN3 PCOLCE	5.72e-06	180	110	6	08ae0f5d95c45feba68ad99788f7af7ff4c979af
ToppCell	droplet-Kidney-KIDNEY-30m-Epithelial-collecting_duct_principal_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UNC13B KIF26B CAGE1 KCND3 HAS3 LY75	5.91e-06	181	110	6	7af469f5bcb9b1ab3f35b2758bf2afb87e8eba57
ToppCell	metastatic_Brain-Fibroblasts-Myofibroblasts\|metastatic_Brain / Location, Cell class and cell subclass	COMP WNT2 THBS2 C1R PDZRN3 PCOLCE	5.91e-06	181	110	6	bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9
ToppCell	P28-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	NRCAM WNT2 IFNGR1 LOXL1 PEAK1 PCOLCE	6.10e-06	182	110	6	19c5e3a9d9b3728303b682102e276adfe93aa759
ToppCell	390C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)\|390C / Donor, Lineage, Cell class and subclass (all cells)	COMP WNT2 THBS2 LOXL1 C1R PCOLCE	6.29e-06	183	110	6	28e1fc6498aaf8f42c4d6d4fa54ffff4c546d0d1
ToppCell	390C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-\|390C / Donor, Lineage, Cell class and subclass (all cells)	COMP WNT2 THBS2 LOXL1 C1R PCOLCE	6.29e-06	183	110	6	667d9107af17fd076ceff6b2cbcb78f892fd62d2
ToppCell	metastatic_Brain-Endothelial_cells-Stalk-like_ECs\|metastatic_Brain / Location, Cell class and cell subclass	FLT4 IL20RA NBPF15 FGD5 PDZRN3 EPAS1	6.70e-06	185	110	6	ad52970e88e8947ef256095bd4b40229b912d58a
ToppCell	healthy_donor-Lymphocytic-Plasma_cell-IgA_Plasmablast\|healthy_donor / Disease condition, Lineage, Cell class and subclass	LAMA5 IGLV2-18 IGLV2-14 MANF IGKV3D-20 IGKV3-20	6.90e-06	186	110	6	e2c050ba02e1f84f0b7258dc92e7ff6ab349ff67
ToppCell	PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	UNC13B EVPL CYFIP2 RASEF HAS3 RBM47	6.90e-06	186	110	6	bb0bfe9a015151be08a6ffc5d82896d0556d76de
ToppCell	droplet-Bladder-Unstain-18m-Epithelial-bladder_mesenchymal_cell_(Scara5+)\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COMP WNT2 WNT2B XDH LOXL1 PCOLCE	7.12e-06	187	110	6	7beba2a5d5978f2ae7d8bde10815705cf2572211
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7\|TCGA-Colorectal / Sample_Type by Project: Shred V9	COMP WNT2 DENND11 THBS2 CHD6 SPATA13	7.34e-06	188	110	6	14bc73cf79c79c9f208369fd8d498e5b26e0114d
ToppCell	343B-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-\|343B / Donor, Lineage, Cell class and subclass (all cells)	FLT4 WNT2B LAMA5 IFNGR1 FGD5 EPAS1	7.34e-06	188	110	6	fe7143c36e4a883745862d3c3147cf751b440e46
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGLV5-45 IGLV5-37 IGLV2-14 MANF IGKV3D-20 IGKV3-20	7.34e-06	188	110	6	6844cebca177fdf38b21a40d606230a033717a3a
ToppCell	343B-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)\|343B / Donor, Lineage, Cell class and subclass (all cells)	FLT4 WNT2B LAMA5 IFNGR1 FGD5 EPAS1	7.34e-06	188	110	6	cbf32b675a7cd0c808d5c9c22dfa7fa79fbe2437
ToppCell	droplet-Lung-LUNG-1m-Mesenchymal-fibroblast_of_lung\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRCAM WNT2 LOXL1 UNC5C ADAMTS17 PCOLCE	7.57e-06	189	110	6	32e6d6285b258831b965281224ff2aaeecdcb5f5
ToppCell	ASK428-Epithelial-Transformed_epithelium\|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq	SPEG CMYA5 F5 THBS2 C1R PCOLCE	7.57e-06	189	110	6	87189275234b5d59484c58acbb14a09903f2b578
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SPATA6 WNT2 CMYA5 IGSF10 UNC5C PDZRN3	7.57e-06	189	110	6	203c80030df08ae112f9ae4043709f455d87ce89
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NRCAM KIF26B WNT2 UNC5C PDZRN3 PCOLCE	7.57e-06	189	110	6	2a22b9fae70afb3dab8476f9c00e48a4df756410
ToppCell	droplet-Lung-LUNG-1m-Mesenchymal-Alveolar_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRCAM WNT2 LOXL1 UNC5C ADAMTS17 PCOLCE	7.57e-06	189	110	6	385ef7bbd76c8047aeecf6542377d4213b5da5db
ToppCell	Control-Endothelial-VE_Capillary_B\|Endothelial / Disease state, Lineage and Cell class	UNC13B WNT2B RAPGEF1 IFNGR1 EPAS1 SPATA13	7.80e-06	190	110	6	7f3f419fffe02934b6f27b697f7a6401072491ed
ToppCell	E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal\|E16.5-samps / Age Group, Lineage, Cell class and subclass	NRCAM WNT2 XDH UNC5C ADAMTS17 PEAK1	8.03e-06	191	110	6	3379d145d34f89150f7b06d1340022cfc6b4a6ce
ToppCell	ASK440-Mesenchymal\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	COMP IGSF10 THBS2 C1R PDZRN3 PCOLCE	8.03e-06	191	110	6	f12959eebb4167e1aa03de05d7711a702c58b3c9
ToppCell	ASK440-Mesenchymal-Fibroblast\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	COMP IGSF10 THBS2 C1R PDZRN3 PCOLCE	8.03e-06	191	110	6	387296b5377ef6839f0812e5b3529a10b5f7d530
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NRCAM WNT2 IGSF10 UNC5C PDZRN3 PCOLCE	8.28e-06	192	110	6	6f4ef24dab544681304b7f8a9dc073e7edaa4cf5
ToppCell	PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	UNC13B NRCAM CYFIP2 MTMR7 HAS3 RBM47	8.28e-06	192	110	6	25378b5e4b0cea8415ff125783511fc25a56fc00
ToppCell	facs-Marrow-KLS-18m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LOXL1 UNC5C ADAMTS17 PDZRN3 EPAS1 PCOLCE	8.28e-06	192	110	6	be75783d9578974b662e1cb13bd3442a921fd50a
ToppCell	PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	UNC13B NRCAM MTMR7 RASEF HAS3 RBM47	8.28e-06	192	110	6	d3634574b2e8d2ded6446969361b70761b331aea
Disease	coronary artery disease	WNT3 PKD2L1 APOB KAT2A INO80 IGSF10 CMIP R3HCC1L LOXL1 UNC5C C1R FGD5 RBM47	1.79e-04	1194	99	13	EFO_0001645
Disease	common bile duct neoplasm (is_marker_for)	APOB MUC5AC	3.08e-04	8	99	2	DOID:4608 (is_marker_for)
Disease	glycosyl-N-stearoyl-sphingosine (d18:1/18:0) measurement	ATP10D CNGA1	3.95e-04	9	99	2	EFO_0800275
Disease	serum alanine aminotransferase measurement	BRIP1 CFL2 LAMA5 PKD2L1 XDH APOB CMYA5 ATP10D CYFIP2 RASEF	6.84e-04	869	99	10	EFO_0004735
Disease	Metastatic melanoma	FLT4 TAF1 PEAK1	8.03e-04	54	99	3	C0278883
Disease	vital capacity	NBPF12 WNT3 WNT2B FRMPD1 APOB INO80 IFNGR1 THBS2 CMIP R3HCC1L LOXL1 ADAMTS17	8.89e-04	1236	99	12	EFO_0004312
Disease	triacylglycerol 52:3 measurement	PKD2L1 APOB	1.14e-03	15	99	2	EFO_0010415
Disease	P wave duration	KCND3 EPAS1	1.14e-03	15	99	2	EFO_0005094
Disease	Lipidemias	APOB PPARGC1B	1.47e-03	17	99	2	C1706412
Disease	Hyperlipidemia	APOB PPARGC1B	1.47e-03	17	99	2	C0020473
Disease	brain infarction	THBS2 RBM47	1.65e-03	18	99	2	EFO_0004277
Disease	diastolic blood pressure, systolic blood pressure	UNC13B BRIP1 SPEG CAGE1 THBS2 CMIP LOXL1 CHD6	1.90e-03	670	99	8	EFO_0006335, EFO_0006336
Disease	Antihypertensive use measurement	WNT2B INO80 CMIP FGD5 RBM47	2.03e-03	265	99	5	EFO_0009927
Disease	maximal midexpiratory flow rate	BRIP1 TUBGCP6	2.04e-03	20	99	2	EFO_0004313
Disease	cancer (implicated_via_orthology)	FLT4 GDI1 GDI2 EPAS1 ACAP3	2.13e-03	268	99	5	DOID:162 (implicated_via_orthology)
Disease	epilepsy (implicated_via_orthology)	UNC13B NRCAM MINK1 MAP4K4	2.25e-03	163	99	4	DOID:1826 (implicated_via_orthology)
Disease	portal hypertension (biomarker_via_orthology)	XDH F5	2.46e-03	22	99	2	DOID:10762 (biomarker_via_orthology)
Disease	Down syndrome (is_marker_for)	BRIP1 GDI2	2.46e-03	22	99	2	DOID:14250 (is_marker_for)

Protein segments in the cluster

Peptide	Gene	Start	Entry
FESYLLPELTRYDCE	EPAS1	831	Q99814
CLPDTYVRDGEYCDS	ADAM5	191	Q6NVV9
EYESTLCEDAYGTLD	CAGE1	76	Q8TC20
AYDDDTTSLLRDCYL	SSX2IP	411	Q9Y2D8
NLRYRCNDTIPEDYE	COMP	736	P49747
QPYEYRLDEFTCADC	GRM2	526	Q14416
YSCYEEFINSRDNSP	CMIP	336	Q8IY22
DTEDYYTLLGCDELS	DNAJC12	11	Q9UKB3
YRESPDSCYSERLDR	ACAP3	366	Q96P50
AYYQAVDLDECASRS	C1R	136	P00736
YCTRPVDREQYESFE	DSC2	196	Q02487
LCYEAESPDEAALVY	ATP10D	721	Q9P241
PRAEEACEDYSGCYE	ADAMTS17	961	Q8TE56
RDADVQTDPYSAEYV	CFAP91	196	Q7Z4T9
DYYNHEVPDIDLSDC	R3HCC1L	626	Q7Z5L2
CYRTDDEDDIGIYIS	PDZRN3	436	Q9UPQ7
AAEAAQQPSYVYSCD	RBM47	336	A0AV96
DLEPDTYCRYDSVSV	PCOLCE	206	Q15113
STLRDPNEYDSEVEY	RASEF	441	Q8IZ41
EYNPPDSEYCRCASA	KAT2A	806	Q92830
PLDSYCNDRSAEYER	INO80	1021	Q9ULG1
RISGLQPEDEADYYC	IGLV5-52	101	A0A0A0MRZ9
PYSCRENYSDSEEED	LEMD3	251	Q9Y2U8
LISGLQSEDEADYYC	IGLV5-37	101	A0A075B6J1
RSFISNDECPSEYYH	DEFB131A	21	P59861
ACDENPDATYDYRSD	MAP4K4	201	O95819
LYRTDDYLDQPCYET	GDI2	191	P50395
PRYECISAYDDELAF	KCND3	106	Q9UK17
AECDIYSYNPDLDSD	MAF1	161	Q9H063
LSSREEIASYYHCPE	TAT	116	P17735
ISRLEPEDFAVYYCQ	IGKV3D-20	96	A0A0C4DH25
LISGLQSEDEADYYC	IGLV5-39	101	A0A0G2JS06
NVLPEDTREDYICYA	NRCAM	206	Q92823
VNRDYRVCDSYPTEL	MTMR7	151	Q9Y216
RNTDNIIYPEEYSSC	MMRN1	1031	Q13201
RQEEPDSLSYYCAAE	KIF26B	1546	Q2KJY2
CLASTAYAPEATDYD	LOXL1	401	Q08397
PLNDCRYALYDATYE	CFL2	76	Q9Y281
DQIAPESDYSLRAYC	MORC3	241	Q14149
LQRICAVDYDDSYDE	PEAK1	301	Q9H792
YELQADTYRCSLEPT	EVPL	821	Q92817
TDYLNNLCPDSAEYD	FGD5	1051	Q6ZNL6
SYCYAVRLSAAEDPL	LSS	241	P48449
EYYRLLNVEEGCSAD	DNAJC28	51	Q9NX36
DTAAVAYDPTENECY	KLHL41	311	O60662
AYDPTENECYLTALA	KLHL41	316	O60662
EESLCDQPYHEIYTR	LY75	146	O60449
ISGLQAEDEADYYCS	IGLV2-18	96	A0A075B6J9
RNVPYSGYDCDDLSV	TUBGCP6	141	Q96RT7
EPARYYEACVNDACA	MUC5AC	1111	P98088
RYADLTEDQLPSYES	PGAM4	141	Q8N0Y7
TDCYYDPEVDRRRAS	LAMA5	366	O15230
DCPGTAEEYERATRY	CYFIP2	426	Q96F07
NRTYCDLSAETSDYE	IL20RA	91	Q9UHF4
ENRLCYYIGATDDAA	MANF	71	P55145
ANAEYLVERDYESAC	BRIP1	451	Q9BX63
VLTEDEADYYCLSGD	IGLV3-22	96	A0A075B6J6
DDCTGDEDYTYLILR	APOB	476	P04114
CISSNYDDADILTYR	IGSF10	551	Q6WRI0
DDYDRDGNCHSQDYP	CHD6	2031	Q8TD26
PSVRESDAEQYYCVA	FCRL1	171	Q96LA6
PSASLESVDDVCYYD	FRMPD1	856	Q5SYB0
ESVDDVCYYDREPYL	FRMPD1	861	Q5SYB0
YVQSDCDPPSDRDSY	FUT10	216	Q6P4F1
LLYSQEVEEDYNPCE	DENND11	371	A4D1U4
SYCIFEDLEPDRCYQ	CMYA5	3766	Q8N3K9
LTPEDEDLYLSYCSQ	DRC7	816	Q8IY82
PYFLDLRLYDTECDN	GABBR2	96	O75899
ISRLEPEDFAVYYCQ	IGKV3-20	96	P01619
LYRTDDYLDQPCLET	GDI1	191	P31150
SVALCIAAYQEDPDY	HAS3	86	O00219
DSLLQRQSDEYSYPE	C5orf34	316	Q96MH7
EQEVDYDPETTCYIR	IFNGR1	156	P15260
ISGLQAEDEADYYCS	IGLV2-14	96	P01704
ETADAPARLEYYENA	IRS4	101	O14654
ACDENPDATYDYRSD	MINK1	201	Q8N4C8
PRDLDYSRYCPTDQA	NR4A3	411	Q92570
SYCRERFDPDEYSTA	GAREM2	346	Q75VX8
DDYAADESCAPRGYL	SZT2	2011	Q5T011
CRYELPTDDDTYEEH	RNF181	116	Q9P0P0
SIEDEEYSNPSCYVR	BMT2	346	Q1RMZ1
EYSNPSCYVRSDIED	BMT2	351	Q1RMZ1
SCYVRSDIEDEQLAY	BMT2	356	Q1RMZ1
NDAQCLTRPYYSDVD	F5	496	P12259
LISGLQSEDEADYYC	IGLV5-45	101	A0A087WSX0
DSCQPYRSSFYALEE	NBPF12	1316	Q5TAG4
LQDSLDRCYSTPSDY	NBPF15	436	Q8N660
DSESRYPQALVCYQE	MITD1	26	Q8WV92
LQPLCHSDYDEDDYD	TAF1	131	P21675
RASEEYECYVIPEEE	FSD2	156	A1L4K1
RYTDYDSNSEEALPA	PPARGC1B	986	Q86YN6
DAYVSYSDCPEDRKF	SIGIRR	166	Q6IA17
LCNSPLEFDEETLYY	SH3TC1	1221	Q8TE82
VYAAEPSNADDCYQS	SRR	206	Q9GZT4
ARACFDELQSDYLEY	CNGA1	181	P29973
EDFSYEDLCQASPRY	SPATA13	116	Q96N96
NDLVYFENSPDYCIR	WNT2	266	P09544
VYELSQPDDDQYCLR	SPEG	1436	Q15772
LTDADCESVYPVVYA	STAG3	421	Q9UJ98
RNTSCETLDHYDPDY	RAPGEF1	376	Q13905
EVPLEEQCEYLSYDA	FLT4	821	P35916
DYYTDDINRACLFVP	EXT2	141	Q93063
SCAYDYLEVRDGPTE	TLL2	516	Q9Y6L7
PDYYLDEADRCTACV	TNFRSF8	71	P28908
ERDLVYYENSPNFCE	WNT3	271	P56703
QASGEAVYCDDIPRY	XDH	586	P47989
AVYCDDIPRYENELS	XDH	591	P47989
CNDSMQSYDLDYPER	UNC13B	236	O14795
FREDILSCYDVYSPD	PKD2L1	216	Q9P0L9
RPQDTVAYEDLSVDY	ZKSCAN7	226	Q9P0L1
ERDNCPYVYNTDQRD	THBS2	811	P35442
EYSIRVYCLDDTQDA	UNC5C	696	O95185
LCRDSAYDSDPEYSS	SPATA6	416	Q9NWH7
SALVNCTNSYDYEEP	UNC45A	591	Q9H3U1
YSLDYPSLREDCQSE	ZNF583	111	Q96ND8
RTDLVYFDNSPDYCV	WNT2B	296	Q93097
YSRTCYDSEDSGREP	USP54	371	Q70EL1